{"action":"elsewhere","city":"Wilmington","companyRegistrationNumber":null,"conformityFlag":"NON_CONFORMING","country":"US","createdAt":"2007-09-21T00:00:00.000Z","entityCategory":"GENERAL","entityStatus":"ACTIVE","entitySubCategory":null,"expirationReason":null,"expiredAt":null,"family":{"children":[],"childrenTotal":0,"exceptions":[{"category":"DIRECT_ACCOUNTING_CONSOLIDATION_PARENT","reasons":["NON_CONSOLIDATING"],"references":[]},{"category":"ULTIMATE_ACCOUNTING_CONSOLIDATION_PARENT","reasons":["NON_CONSOLIDATING"],"references":[]}],"parents":[]},"headquartersAddress":"2nd Floor, 530 Lytton Avenue","headquartersCity":"Palo Alto","headquartersCountry":"US","headquartersPostalCode":"94301","headquartersRegion":"US-CA","lastUpdatedAt":"2026-06-18T20:11:57.019Z","legalAddress":"C/O The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street","legalFormAbbreviation":null,"legalFormCode":"XTIQ","legalFormName":"Corporation","legalJurisdiction":"US-DE","legalName":"Nora Therapeutics, Inc.","lei":"54930076005JR8BF8W90","managingLou":"5493001KJTIIGC8Y1R12","managingLouName":"Bloomberg","managingLouWebsite":"http://lei.bloomberg.com","nextRenewalAt":"2016-04-26T18:49:00.000Z","otherLegalForm":null,"postalCode":"19801","region":"US-DE","registeredAt":"2014-05-29T01:44:00.000Z","registrationAuthorityId":"RA000602","registrationAuthorityName":"Division of Corporations, Department of State","registrationAuthorityWebsite":"https://corp.delaware.gov/","registrationNumber":"4427349","registrationNumberFormatted":"4427349","registrationStatus":"LAPSED","served":false,"successorLeis":[],"validationAuthorityEntityId":"4427349","validationAuthorityId":"RA000602","validationAuthorityName":"Division of Corporations, Department of State","validationSources":"FULLY_CORROBORATED"}